Compare Futu Holdings Ltd (FUTU) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Futu Holdings Ltd vs Hinge Health Inc. Class A Common Stock — how do they compare? Futu Holdings Ltd trades at $107.31 (market cap $15.99B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Futu Holdings Ltd is the larger of the two by market cap, and Futu Holdings Ltd pays a 2.28% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Futu Holdings Ltd for 34 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| FUTU | HNGE | |
|---|---|---|
Market Cap | $15.99B | $8.48B |
Volume | 931,065 | 879,799 |
Sector | Financials | Health |
52-Week High | $199.04 | $105.14 |
52-Week Low | $89.76 | $31.17 |
Typical Hold Time | 34 Days | 0 Days |
Enterprise Value | $16.33B | $8.10B |
Dividend Yield | 2.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FUTU trades at $109.45, down 2.5% today, with a neutral technical signal and mixed earnings history including a recent Q2 2026 beat. The company shows strong profitability with a 42.92% net income margin and 30.8% ROE, while valuation ratios like a P/E of 11.38 suggest potential undervaluation. Recent news highlights expansion efforts, such as Moomoo's partnership with X's Cashtag program, but also ongoing securities class action lawsuits.
The outlook is cautiously optimistic, supported by robust fundamentals and analyst consensus pointing to a 33% upside, though risks from legal challenges and market volatility persist. Revenue growth remains a key catalyst, but investors should weigh the high institutional ownership against regulatory and competitive pressures.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Futu Holdings Ltd
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.
Read more on FUTU →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
